271 Biotech startups in the UK (free list)
Track funded biotech companies, founders and investors across the UK startup ecosystem.
Updated daily by John-Pierre ClarkUpdated daily by John-Pierre Clark| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
26 Oct 2026 |  imphatec A small implant placed under the skin that steadily releases medication ove... | £1,500,000 | |||||||||||
16 Oct 2026 |  Microbiotica MB310 is an oral once-daily live biotherapeutic capsule containing eight sp... | £36,000,000 | |||||||||||
16 Oct 2026 |  Medcotec The Helyx valve is a single-use, full-bore powder transfer valve for pharma... | £2,400,000 | Daresbury  | ||||||||||
16 Oct 2026 |  OMass Therapeutics OMS1620 is a small-molecule drug that binds the MC2 receptor to modify rece... | £233,750,000 US$310,000,000 | |||||||||||
14 Oct 2026 |  HydRegen HydRegen provides a bio-based hydrogenation platform that formulates enzyme... | £6,040,000 US$8,000,000 | |||||||||||
13 Oct 2026 |  Undecimal Bio DELiveri is a platform that uses chemical screening and machine learning to... | £14,000,000 | |||||||||||
12 Oct 2026 |  Sava Technologies Sava Technologies offers a wearable glucose microsensor that measures gluco... | £27,000,000 | |||||||||||
8 Oct 2026 |  Neela Biotech A process using AI to guide microbial communities that convert organic wast... | £2,100,000 | |||||||||||
6 Oct 2026 |  Sensible Biotechnologies A cell-based platform that produces naturally modified mRNA using engineere... | £35,550,000 US$47,000,000 | |||||||||||
29 Sept 2026 |  52North Neutrocheck is a rapid finger prick blood test that uses a biomarker detect... | £3,200,000 | |||||||||||
24 Sept 2026 |  Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
18 Sept 2026 |  Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 |  Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 |  MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | Leeds | ||||||||||
17 Sept 2026 |  Eterna Regeneratives A keratin scaffold that forms a thin layer on tooth and bone surfaces. It i... | ||||||||||||
16 Sept 2026 |  Axo Longevity Axo Longevity is a membership service that provides regular blood panels, a... | £3,710,000 US$5,000,000 | |||||||||||
15 Sept 2026 |  Athernal Bio Athernal Bio develops targeted immunotherapies that recognise and remove hi... | £700,000 | |||||||||||
15 Sept 2026 |  Magnitude Biosciences VivoScan is a platform that tests chemical compounds in living C. elegans u... | £1,300,000 | Durham | ||||||||||
15 Sept 2026 |  Fuse Diagnostics Flip is an instrument-free molecular diagnostics platform combining proprie... | £1,000,000 | |||||||||||
14 Sept 2026 |  Bitrobius Genetics Gentrafix is a plasmid-based platform that replicates in human cells and sp... | £700,000 | Cheshire | ||||||||||
9 Sept 2026 |  ViaNautis polyNaut® is a non-viral delivery platform that uses targeted polymer nanov... | €20,000,000 | |||||||||||
9 Sept 2026 |  Anemo Labs Anemo Labs makes a sensor device that samples urine and analyses scent usin... | £700,000 | |||||||||||
1 Sept 2026 |  Pure Capture Innovations A carbon-based adsorbent and on-site testing service for water treatment th... | £530,000 | |||||||||||
10 Aug 2026 |  Mironid Mironid develops oral small-molecule LoAc compounds that target cAMP signal... | £34,110,000 US$46,000,000 | |||||||||||
29 Jul 2026 |  Qureight Qureight offers an AI imaging platform that combines imaging services with ... | £15,000,000 | |||||||||||
23 Jul 2026 |  Moa Technology Moa Technology offers a discovery platform and product pipeline for herbici... | £22,200,000 | |||||||||||
14 Jul 2026 |  Draig Therapeutics DT-101 is an AMPA receptor potentiator and positive allosteric modulator. I... | £48,640,000 US$65,000,000 | Cardiff | ||||||||||
10 Jul 2026 |  Alchemab Therapeutics Resiliome is a platform that combines deep sequencing of antibodies with a ... | £25,000,000 | |||||||||||
8 Jul 2026 |  Healome Therapeutics Healome Therapeutics makes an eye-drop matrix that is liquid on application... | £2,000,000 | |||||||||||
6 Jul 2026 |  Revolver Therapeutics Revolver Therapeutics provides a discovery platform and peptide therapeutic... | £572 | Bath |
1 Explore 271 UK biotech startups and their founders, who have collectively raised £6.81B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing biotech startups with the full list of recently funded startups from the UK.
Cambridge has always been a major hotspot for Biotech startups but London is now fighting back hard to compensate for the WFH (work from home) trend in finance. In Canary Wharf, a new 23-story life science tower has even been approved!
UK biotech startup insights
The UK has developed one of Europe's strongest biotech ecosystems, centred around research universities in London, Cambridge, Oxford, Manchester and Edinburgh. This list highlights funded biotech startups across pre-seed, seed and later rounds.
Biotech in this context covers therapeutics, diagnostics, synthetic biology, bioinformatics, industrial biotech and environmental applications. Many of these companies combine scientific research with software, data and AI to accelerate development and improve decision-making in clinical or industrial settings.
Snapshot of the UK biotech landscape
- Hundreds of funded biotech startups ranging from early discovery platforms to revenue-generating companies
- Round sizes typically span SEIS and EIS backed seed cheques through to large Series A and growth rounds
- Key hubs include the Golden Triangle, with emerging activity in the North of England and Scotland
- Investors include specialist biotech funds, deeptech VCs, corporate venture arms and experienced angel syndicates
- Common themes include oncology, rare diseases, cell and gene therapy, precision diagnostics, microbiome and lab automation
Use this page to explore the fastest growing biotech startups in the UK, then review individual profiles for websites, investors, locations and recent funding. For filters, exports and deeper analysis, you can upgrade to full database access.
That’s for the fastest growing biotech startups. If you're looking for funding opportunities, check out our list of top biotech investors backing innovative startups.
What is Biotech?
Biotech, short for biotechnology, is a field of science and technology that involves the use of living organisms, cells, and biological systems to develop and create products or applications that benefit various industries.
It combines biology, chemistry, genetics, and other disciplines to manipulate biological systems for practical purposes. Biotechnology has a wide range of applications, including medicine, agriculture, food production, and environmental management.
5 most exciting Biotech sectors
Key areas of biotechnology include:
1 - Medical Biotechnology
Involves the development of pharmaceuticals, vaccines, and diagnostic tools. It also includes gene therapy, where genetic material is used to treat or prevent diseases.
2 - Agricultural Biotechnology
Focuses on improving crop yield, resistance to pests and diseases, and enhancing nutritional content. Genetically modified organisms (GMOs) are an example of agricultural biotechnology.
3 - Industrial Biotechnology
Utilises biological systems to produce chemicals, fuels, and other industrial products. This can include the use of microorganisms for fermentation processes.
4 - Environmental Biotechnology
Addresses environmental issues by developing technologies for waste treatment, pollution control, and sustainable resource management.
5- Bioinformatics
Involves the use of computer science and information technology to analyse biological data, such as DNA sequences and protein structures.
Biotechnology has the potential to revolutionise various industries and improve the quality of life by offering innovative solutions to complex problems. And we haven’t talked about how AI will also impact this race.
The UK has a fantastic opportunity to reinforce its current position and grow into a world leader for biotech startups.
Related biotech and deeptech resources
Frequently asked questions
Biotech startups are companies developing products or technologies using biology, genetics, pharmaceuticals, diagnostics or life sciences research. UK biotech startups commonly operate across therapeutics, synthetic biology, drug discovery, diagnostics, genomics, precision medicine and AI-powered life sciences.
The UK has one of the strongest biotech ecosystems in Europe because of its universities, NHS-linked research infrastructure, scientific talent and specialist life sciences investors. Cambridge, Oxford and London are especially important for biotech spinouts, venture funding and commercialisation.
Biotech startups in the UK typically raise funding through angel investors, venture capital firms, university spinout funds, Innovate UK grants and strategic partnerships. Many biotech companies need larger and longer funding pathways than software startups because of laboratory work, clinical validation and regulation.
A biotech spinout is a startup commercialising scientific research developed within a university, laboratory or research institution. Many UK biotech spinouts originate from institutions such as the University of Cambridge, the University of Oxford, Imperial College London and other research centres.
Biotech startups often take longer to scale because they must prove scientific validity, navigate regulation, run trials or validation studies and reach commercial partnerships. Investors usually expect longer timelines, larger capital requirements and deeper technical risk than in many software markets.